CORCEPT THERAPEUTICS INC Quarterly Costs and Expenses in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Corcept Therapeutics Inc quarterly/annual Costs and Expenses history and growth rate from Q1 2015 to Q3 2024.
  • Corcept Therapeutics Inc Costs and Expenses for the quarter ending September 30, 2024 was $136M, a 47.1% increase year-over-year.
  • Corcept Therapeutics Inc Costs and Expenses for the twelve months ending September 30, 2024 was $485M, a 37.9% increase year-over-year.
  • Corcept Therapeutics Inc annual Costs and Expenses for 2023 was $375M, a 29.7% increase from 2022.
  • Corcept Therapeutics Inc annual Costs and Expenses for 2022 was $289M, a 19.8% increase from 2021.
  • Corcept Therapeutics Inc annual Costs and Expenses for 2021 was $242M, a 7.01% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $485M $136M +$43.5M +47.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $442M $128M +$40.1M +45.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $402M $117M +$26.5M +29.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $375M $104M +$23.2M +28.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $352M $92.4M +$22.6M +32.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $329M $88.1M +$16.2M +22.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-29
Q1 2023 $313M $90.8M +$23.9M +35.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $289M $80.6M +$18.4M +29.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $271M $69.8M +$9.9M +16.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $261M $72M +$12.3M +20.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $249M $66.9M +$7.12M +11.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $242M $62.2M +$6.93M +12.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $235M $59.9M -$1.71M -2.77% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $236M $59.6M +$6.34M +11.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $230M $59.8M +$4.26M +7.68% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $226M $55.2M +$2.34M +4.43% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $223M $61.6M +$13.1M +27% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $210M $53.3M +$5.68M +11.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $205M $55.5M +$9.66M +21.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $195M $52.9M +$10.9M +26.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-15
Q3 2019 $184M $48.5M +$7.03M +16.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $177M $47.6M +$5.95M +14.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $171M $45.9M +$9.21M +25.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 $162M $41.9M +$10.4M +32.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $151M $41.5M +$12.3M +42.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $139M $41.7M +$18.9M +83.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $120M $36.7M +$13.8M +60.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $106M $31.6M +$12.8M +68% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $93.6M $29.1M +$10.5M +56.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $83.1M $22.8M +$4.55M +25% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $78.5M $22.9M +$7.39M +47.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $71.1M $18.8M +$5.49M +41.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $65.7M $18.7M +$5.49M +41.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $60.2M $18.2M +$5.09M +38.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $55.1M $15.5M +$1.34M +9.46% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 $53.7M $13.3M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $13.2M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $13.1M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $14.1M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.